TOPICS / TUMOR TYPE

Prostate cancer

Prostate cancer — an emerging, typically low-TMB target for therapeutic cancer vaccines.

Topic1 item2026-05-29

Tumor types

Melanoma10 Pancreatic cancer9 Glioblastoma9 Colorectal cancer7 Lung cancer (NSCLC)6 Lynch syndrome5 Kidney cancer (RCC)5 Breast cancer5 Head & neck cancer2 Liver cancer (HCC)2 Gastric cancer1 Bladder cancer1 Prostate cancer1

Clinical

YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer

Changhai Hospital is testing YS247, a personalized neoantigen-pulsed dendritic cell vaccine, for metastatic castration-resistant prostate cancer. The Phase I study aims to determine safety and the maximum tolerated dose across three dose levels, while monitoring PSA levels and immune stimulation.

clinicaltrials · brief 2026-05-29 · published 2026-05-13